Caitong International Asset Management Co., LTD Heron Therapeutics, Inc. Transaction History
Caitong International Asset Management Co., LTD
- $102 Billion
- Q4 2024
A detailed history of Caitong International Asset Management Co., LTD transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 630 shares of HRTX stock, worth $1,121. This represents 0.0% of its overall portfolio holdings.
Number of Shares
630
Previous 630
-0.0%
Holding current value
$1,121
Previous $964,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding HRTX
# of Institutions
174Shares Held
114MCall Options Held
1.99MPut Options Held
65.8K-
Rubric Capital Management LP New York, NY26.7MShares$47.6 Million0.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.5MShares$15.1 Million0.02% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$14.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.16MShares$14.5 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$12.4 Million22.07% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $211M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...